Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Maiden Drill Program Commences at Oasis Uranium Project July 28, 2025 Next Post GTI Energy July 28, 2025 Related Posts Sun Summit Announces Upsized Non-Brokered Private Placement of up to $11.5 Million December 13, 2025 Contango ORE, Dolly Varden Announce Strategic Silver Merger December 13, 2025 PPC, Lundin Freeze 2026 Processing Fees as Smelters Near Breaking Point December 13, 2025